Victoria P. Werth

Efficacy, safety, and target engagement of dazukibart, an IFNβ specific monoclonal antibody, in adults with dermatomyositis: a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial

2025 American College of Rheumatology ( <scp>ACR</scp> ) Guideline for the Treatment of Systemic Lupus Erythematosus

RANDOMIZED, PLACEBO-CONTROLLED PHASE II STUDY OF ENPATORAN, A SMALL MOLECULE TOLL-LIKE RECEPTOR 7/8 INHIBITOR, IN CUTANEOUS LUPUS ERYTHEMATOSUS: RESULTS FROM COHORT A

2025 American College of Rheumatology ( <scp>ACR</scp> ) Guideline for the Treatment of Systemic Lupus Erythematosus

POS1123 Myositis Community Proposes a Framework to Guide Clinical Trials and Ensure Patient Safety during Influx of CAR-Based Therapies

Clinical Characteristics of Anti‐Synthetase Syndrome: Analysis From the Classification Criteria for Anti‐Synthetase Syndrome Project

Agreement between local and central anti-synthetase antibodies detection: results from the Classification Criteria of Anti-Synthetase Syndrome project biobank

Advances in Pemphigus and Pemphigoid: A Report of the International Meeting of the Pemphigus and Pemphigoid Foundation in Thessaloniki, Greece

International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening: an International Myositis Assessment and Clinical Studies Group (IMACS) initiative

Efficacy of intravenous immunoglobulins (IVIg) in improving skin symptoms in patients with dermatomyositis: a post-hoc analysis of the ProDERM study

Development and Validation of the Morphea Activity Measure in Patients With Pediatric Morphea

Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases

Trial of Anti-BDCA2 Antibody Litifilimab for Cutaneous Lupus Erythematosus

Trial of Anti-BDCA2 Antibody Litifilimab for Systemic Lupus Erythematosus

Defining anti-synthetase syndrome: a systematic literature review

Rho Kinase regulates neutrophil NET formation that is involved in UVB-induced skin inflammation

2021 DORIS definition of remission in SLE: final recommendations from an international task force

American College of Rheumatology, American Academy of Dermatology, Rheumatologic Dermatology Society, and American Academy of Ophthalmology 2020 Joint Statement on Hydroxychloroquine Use With Respect to Retinal Toxicity

AB014. Developing classification criteria for skin-predominant dermatomyositis: assessing the methodology of the prospective validation study

Nuclear envelope rupture and NET formation is driven by PKCα‐mediated lamin B disassembly

Comparison of the 2019 European Alliance of Associations for Rheumatology/American College of Rheumatology Systemic Lupus Erythematosus Classification Criteria With Two Sets of Earlier Systemic Lupus Erythematosus Classification Criteria

239th ENMC International Workshop: Classification of dermatomyositis, Amsterdam, the Netherlands, 14–16 December 2018

Nuclear lamin B is crucial to the nuclear envelope integrity and extracellular trap release in neutrophils

Diagnosis and management of pemphigus: Recommendations of an international panel of experts

Efficacy and safety of ustekinumab, an IL-12 and IL-23 inhibitor, in patients with active systemic lupus erythematosus: results of a multicentre, double-blind, phase 2, randomised, controlled study

Classification of myositis

Lupus community panel proposals for optimising clinical trials: 2018

Advances in Cutaneous Lupus Erythematosus and Dermatomyositis: A Report from the 4th International Conference on Cutaneous Lupus Erythematosus—An Ongoing Need for International Consensus and Collaborations

2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups

2017 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups